<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Gastroparesis: Etiology, clinical manifestations, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Gastroparesis: Etiology, clinical manifestations, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Gastroparesis: Etiology, clinical manifestations, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael Camilleri, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nicholas J Talley, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shilpa Grover, MD, MPH, AGAF
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 15, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Normal gastrointestinal motor function is a complex series of events that requires coordination of the sympathetic and parasympathetic nervous systems, neurons and pacemaker cells (called interstitial cells of Cajal) within the stomach and intestine, and the smooth muscle cells of the gut. Abnormalities of this process can lead to a delay in gastric emptying (gastric stasis) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         This topic will review the etiology and diagnosis of gastroparesis. Our recommendations are largely consistent with guidelines by the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) [
         <a href="#rid2">
          2,3
         </a>
         ]. The pathogenesis and treatment of gastroparesis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2638.html" rel="external">
          "Pathogenesis of delayed gastric emptying"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2532.html" rel="external">
          "Treatment of gastroparesis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H259165300">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastroparesis is a syndrome of objectively delayed gastric emptying of solids in the absence of a mechanical obstruction and cardinal symptoms of nausea, vomiting, early satiety, belching, bloating, and/or upper abdominal pain [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         In one of the largest population-based studies that identified 3604 potential cases of gastroparesis, of whom 83 fulfilled diagnostic criteria for definite gastroparesis, the age-adjusted incidence of gastroparesis was 2.4 per 100,000 person-years for men, 9.8 per 100,000 person-years for women, and 6.3 per 100,000 person-years for the combined cohort of men and women [
         <a href="#rid5">
          5
         </a>
         ]. The age-adjusted prevalence of definite gastroparesis (based on symptoms and delayed gastric emptying measured by scintigraphy) was 9.6 per 100,000 persons for men and 38 per 100,000 persons for women. In an epidemiologic study from Europe, the estimated overall prevalence of gastroparesis was 13.8 per 100,000 persons with an incidence of 1.9 per 100,000 person-years [
         <a href="#rid6">
          6
         </a>
         ]. A systematic review of the literature concluded that the prevalence of definite gastroparesis (symptoms plus evidence of delayed gastric emptying) in the general population ranged from 13.8 to 267.7 per 100,000 adults, and the incidence ranged from 1.9 to 6.3 per 100,000 person-years [
         <a href="#rid7">
          7
         </a>
         ]. Across studies, gastroparesis was more common among females. Overall survival was significantly lower in patients with diabetes and in those with gastroparesis than for the age- and sex-matched general population [
         <a href="#rid5">
          5,6
         </a>
         ]. However, other estimates have been lower. In a United States cross-sectional population-based study using electronic medical records and results of upper gastrointestinal endoscopy and gastric emptying tests, the prevalence of gastroparesis in type 1 and type 2 diabetics was 4.6 and 1.3 percent, respectively [
         <a href="#rid8">
          8
         </a>
         ]. Overall, there were about 70,000 people with gastroparesis out of the 44 million people based on the electronic medical records, and the diagnosis was confirmed by the tests in only about 14 percent of those with a record of gastroparesis. Overall, these data suggest a calculated prevalence of 0.16 percent.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although multiple conditions have been associated with gastroparesis, the majority of cases are idiopathic, diabetic, iatrogenic (eg, medication-induced), or postsurgical  (
         <a class="graphic graphic_figure graphicRef139600" href="/z/d/graphic/139600.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Idiopathic
         </span>
         <span class="headingEndMark">
          —
         </span>
         Idiopathic gastroparesis may be the most common form of gastroparesis. It is estimated that no detectable primary underlying abnormality is found in approximately one-half of patients with delayed gastric emptying [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Diabetes mellitus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diabetes mellitus (DM)
         <em>
         </em>
         is the most frequently recognized systemic disease associated with gastroparesis. Population-based studies in patients with diabetes mellitus have reported upper gastrointestinal symptoms in 11 to 18 percent of patients [
         <a href="#rid10">
          10-13
         </a>
         ]. The estimated 10-year cumulative incidence of gastroparesis in patients with type 1 DM and type 2 DM was estimated to be 5.2 and 1 percent, respectively [
         <a href="#rid7">
          7
         </a>
         ]. In studies from referral centers and hence potentially biased to select for patients with relatively severe disease, 50 to 65 percent of patients with diabetes and upper abdominal symptoms had delayed gastric emptying [
         <a href="#rid14">
          14-16
         </a>
         ]. However, in a population-based cohort study, the cumulative incidence of gastroparesis over 10 years in patients with type 1 and type 2 DM was 5 percent and 1 percent, respectively, as compared with 0.2 percent in controls [
         <a href="#rid17">
          17
         </a>
         ]. Symptoms of delayed gastric emptying are more pronounced in patients with type 1 DM as compared with patients with type 2 DM [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2643.html" rel="external">
          "Diabetic autonomic neuropathy of the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
         Gastrointestinal complications of diabetes typically occur in patients who have had the disorder for more than five years. Patients with diabetes mellitus have abnormalities at several levels in the process of gastric emptying, including abnormal postprandial proximal gastric accommodation and contraction, and reduced frequency of antral contractions. These abnormalities are primarily due to autonomic dysfunction or abnormal intrinsic nervous system (eg, nitrergic neurons, or interstitial cells of Cajal, the pacemaker system of the gut) [
         <a href="#rid19">
          19-21
         </a>
         ].
        </p>
        <p>
         An alternative theory implicates a role for oxidative stress in the pathogenesis of diabetic gastroparesis [
         <a href="#rid22">
          22-24
         </a>
         ]. Observations based predominantly on animal models of diabetes suggest that oxidative stress is associated with an increased number of macrophages and up-regulation of heme-oxygenase-1 (HO1) in CD206(+) M2 macrophages. Indeed, onset of delayed gastric emptying in these models of diabetic gastroparesis was not associated with alteration in the total number of macrophages, but a selective loss of the protective CD206(+)/HO1(+) M2 macrophages [
         <a href="#rid23">
          23
         </a>
         ]. The clinical relevance of this oxidative stress was explored by studying the effects of
         <a class="drug drug_general" data-topicid="8970" href="/z/d/drug information/8970.html" rel="external">
          hemin
         </a>
         in a small randomized controlled trial; unfortunately, hemin, which was previously shown to activate HO-1 in humans, failed to sustain increased HO1 levels beyond a week and did not improve gastric emptying or symptoms in diabetic gastroparesis [
         <a href="#rid25">
          25
         </a>
         ]. Therefore, the clinical relevance and potential to reverse effects of oxidative stress on intrinsic neural or ICC pathways in diabetic gastroparesis is still unclear.
        </p>
        <p>
         Hyperglycemia (blood glucose &gt;200 mg/dL) may also contribute to delayed gastric emptying. Although acute hyperglycemia, associated with poorly controlled diabetes, typically has a reversible effect on gastric emptying, chronic hyperglycemia is associated with an increased risk of neuropathy. The pathogenesis of delayed gastric emptying in diabetes is discussed in detail, separately. (See
         <a class="medical medical_review" href="/z/d/html/2643.html" rel="external">
          "Diabetic autonomic neuropathy of the gastrointestinal tract", section on 'Pathogenesis'
         </a>
         .)
        </p>
        <p>
         There is increased appreciation of the impact of risk factors on gastroparesis, particularly in urban centers [
         <a href="#rid26">
          26
         </a>
         ], and these include prescriptions for narcotic medications and the presence of comorbid risk factors, of which the most prevalent was type 2 diabetes.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Viral
         </span>
         <span class="headingEndMark">
          —
         </span>
         A subset of patients with gastroparesis report sudden onset of symptoms after a viral prodrome, suggesting a viral etiology. Several reports have documented the occurrence of gastric stasis in association with prior viral infections, including Norwalk virus and rotavirus [
         <a href="#rid27">
          27-29
         </a>
         ].
        </p>
        <p>
         Postviral gastroparesis often improves over one year [
         <a href="#rid28">
          28,30,31
         </a>
         ]. However, a small proportion of patients with infections due to viruses such as cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus may develop severe dysautonomia or even selective cholinergic dysautonomia leading to persistent symptoms due to extrinsic autonomic denervation [
         <a href="#rid32">
          32,33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several medications can delay gastric emptying. These include [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Narcotics (affecting mu opiate receptors alone or combined with inhibition of norepinephrine reuptake [eg,
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         and
         <a class="drug drug_general" data-topicid="9511" href="/z/d/drug information/9511.html" rel="external">
          tapentadol
         </a>
         , respectively]) [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alpha-2-adrenergic agonists (eg,
         <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">
          clonidine
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tricyclic antidepressants [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Calcium channel blockers.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dopamine agonists.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Muscarinic cholinergic receptor antagonists.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9714" href="/z/d/drug information/9714.html" rel="external">
          Octreotide
         </a>
         [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glucagon-like peptide (GLP)-1 agonists (eg,
         <a class="drug drug_general" data-topicid="9005" href="/z/d/drug information/9005.html" rel="external">
          exenatide
         </a>
         ) or analogues (eg,
         <a class="drug drug_general" data-topicid="9522" href="/z/d/drug information/9522.html" rel="external">
          liraglutide
         </a>
         ) and amylin analogues [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Phenothiazines [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          Cyclosporine
         </a>
         (but not
         <a class="drug drug_general" data-topicid="9971" href="/z/d/drug information/9971.html" rel="external">
          tacrolimus
         </a>
         , which is derived from macrolide molecule like
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         , and does not inhibit gastric emptying).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immune checkpoint inhibitor therapy [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H607739525">
         <span class="h2">
          Postsurgical
         </span>
         <span class="headingEndMark">
          —
         </span>
         Previous gastric and thoracic surgery can result in gastric stasis due to intended or accidental injury to the vagus nerves (eg, with Billroth II gastrectomy, fundoplication, lung or heart transplantation, paraesophageal hernia repair) [
         <a href="#rid40">
          40,41
         </a>
         ]. Other cases of gastroparesis have been rarely reported in patients after duodenal switch, or biliopancreatic diversion or after Roux-en-Y gastric bypass for obesity [
         <a href="#rid42">
          42,43
         </a>
         ]. Extrinsic vagal denervation or loss of the antrum reduces the capacity of the stomach to empty nondigestible solids during fasting, resulting in bezoar formation, and to triturate and empty digestible food postprandially. (See
         <a class="medical medical_review" href="/z/d/html/2638.html" rel="external">
          "Pathogenesis of delayed gastric emptying"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2535.html" rel="external">
          "Gastric bezoars", section on 'Pathogenesis'
         </a>
         .)
        </p>
        <p>
         Fundoplication is one of the most common surgical procedures leading to reversible or permanent vagal injury. Other causes of vagal injury include variceal sclerotherapy and botulinum toxin injection for medical treatment of achalasia [
         <a href="#rid44">
          44-46
         </a>
         ] and radiofrequency ablation for atrial fibrillation [
         <a href="#rid47">
          47
         </a>
         ]. Vagal injury can be demonstrated by measurement of the plasma pancreatic polypeptide (PP) response to modified sham feeding. With normal physiology, sham feeding, which consists of chewing but not swallowing food, results in cephalic vagal stimulation and thereby a rapid increase in plasma PP of at least 25 pg/mL in the first 20 minutes followed by a return to baseline. In patients with vagal injury, sham feeding is not associated with an increase in PP over baseline. In a generalized neuropathy or injury to the vagus nerve between the brainstem and the level of the heart, evidence of vagal injury can also be appraised by the heart period response to deep breathing (six times per minute); breathing results in sinus arrhythmia through a vagally-mediated reflex. Vagal injury or denervation results in a loss of sinus arrhythmia. This can be initially appraised on a standard 12-lead electrocardiogram. Loss of sinus arrhythmia may be reversible (eg, over several months after radiofrequency ablation for atrial fibrillation) [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
         Roux stasis syndrome can occur after a Roux-en-Y anastomosis. Uncoordinated contractions in the efferent Roux limb itself causes stasis either in the gastric remnant or in the Roux limb itself.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Neurologic disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several common neurologic disorders are associated with dysmotility of the upper gastrointestinal tract and resultant gastroparesis  (
         <a class="graphic graphic_figure graphicRef139600" href="/z/d/graphic/139600.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Extrinsic neural control (eg, the vagus nerve and lower thoracic spinal sympathetic outflow) may be affected in disorders such as multiple sclerosis, brainstem stroke or tumor, Parkinsonism, diabetic or amyloid neuropathy, or primary dysautonomias.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The myenteric plexus may be involved in a degenerative, diffuse neurologic disorder (eg, diabetes, AIDS, or parkinsonism). Focal loss of intrinsic inhibitory innervation of the pylorus is responsible for congenital pyloric stenosis. In Parkinson disease, enteric nervous system dysfunction has been reported to precede motor symptoms by years to decades [
         <a href="#rid48">
          48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4903.html" rel="external">
          "Clinical manifestations of Parkinson disease", section on 'Cardinal features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medications used to treat neurologic disease can also contribute to gastric stasis (eg, anticholinergics, dopaminergics). (See
         <a class="local">
          'Medications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastroparesis may be a manifestation of autonomic dysfunction. In a study of 242 patients with chronic gastroparetic symptoms, parasympathetic dysfunction was associated with delayed gastric emptying and more severe upper gastrointestinal symptoms [
         <a href="#rid49">
          49
         </a>
         ]. Conversely, sympathetic hypofunction was associated with milder symptoms.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Autoimmune
         </span>
         <span class="headingEndMark">
          —
         </span>
         Delayed gastric emptying has been described in association with autoimmune gastrointestinal dysmotility [
         <a href="#rid50">
          50,51
         </a>
         ]. Autoimmune gastrointestinal dysmotility is a dysautonomia affecting the gastrointestinal tract that occurs idiopathically or in association with an anatomically remote neoplasm, most commonly small cell lung cancer. In addition to delayed gastric emptying, affected patients may have slow intestinal transit, slow colonic transit, and pelvic floor dyssynergia. The role of the autoimmune process in cases of acquired dysautonomia manifesting with symptoms that include gastroparesis is illustrated by the response to plasmapheresis treatment [
         <a href="#rid52">
          52
         </a>
         ]. In a retrospective analysis of 11 female patients with drug- and device-resistant gastroparesis who had coexisting positive autoimmune profiles, treatment for 8 to 12 weeks with diverse immunomodulatory treatment showed total symptom score improvement in 6 out of 11 patients, with maximum gastrointestinal symptom improvement with intravenous immunoglobulin (2 out of 3 patients treated) [
         <a href="#rid53">
          53
         </a>
         ]. In a subsequent open-label study, which included 14 patients (3 diabetic, 1 postsurgical, and 10 idiopathic gastroparesis) with serological and/or tissue evidence of immunological abnormality, intravenous immunoglobulin (400 mg/kg infusion weekly for 12 weeks) was associated with significant improvement in nausea, vomiting, early satiety, and abdominal pain, with 9 out of 14 patients declared as responders to this open-label treatment [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5190.html" rel="external">
          "Paraneoplastic syndromes affecting spinal cord, peripheral nerve, and muscle", section on 'Autonomic neuropathy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H607739622">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other causes of gastroparesis include mesenteric ischemia and diseases that result in infiltration or degeneration of the muscle layer of the stomach (eg, scleroderma). Patients with gastric or intestinal involvement due to scleroderma usually have clinically evident systemic disease involving the skin, lungs, and/or the esophagus [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7548.html" rel="external">
          "Gastrointestinal manifestations of systemic sclerosis (scleroderma)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7539.html" rel="external">
          "Clinical manifestations and diagnosis of systemic sclerosis (scleroderma) in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H259165581">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H259165942">
         <span class="h2">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with gastroparesis can present with nausea (93 percent), vomiting (68 to 84 percent), abdominal pain (46 to 90 percent), early satiety (60 to 86 percent), postprandial fullness, bloating, and, in severe cases, weight loss [
         <a href="#rid9">
          9,56
         </a>
         ]. The vomitus may contain food ingested several hours previously.
        </p>
        <p>
         The predominant symptom may vary based on the underlying etiology. In a retrospective study that included 416 patients with gastroparesis, patients with idiopathic gastroparesis reported more early satiety, postprandial fullness, and abdominal pain as compared with patients with diabetic gastroparesis. In contrast, patients with diabetic gastroparesis had more severe retching and vomiting [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         Bloating is common in gastroparesis and is severe in many individuals. In one study of 335 individuals with gastroparesis, bloating was at least mild in 76 percent and severe in 41 percent of individuals [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         While abdominal pain is a frequent symptom in patients with gastroparesis, it is rarely the predominant symptom (18 percent). In patients whose predominant symptom is abdominal pain, other causes should be sought [
         <a href="#rid58">
          58
         </a>
         ]. The pain is usually localized to the upper abdomen and is often described as burning, vague, or crampy. Approximately 60 percent report exacerbation of pain after eating. In one case series, pain interfered with sleep in 80 percent of patients. However, the severity of abdominal pain did not correlate with a delay in gastric emptying, suggesting that the cause of pain in this tertiary referral cohort may not have been gastroparesis [
         <a href="#rid59">
          59
         </a>
         ]. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         In the cohort of 506 patients assessed in the National Institute of Health gastroparesis consortium, abdominal pain was reported to be common in patients with gastroparesis, both idiopathic and diabetic. Severe or very severe upper abdominal pain occurred in 34 percent of the patients with gastroparesis and was associated with other symptoms of gastroparesis, somatization, anxiety, impaired quality of life, and opiate medication use [
         <a href="#rid60">
          60
         </a>
         ], as well as cannabis use [
         <a href="#rid61">
          61
         </a>
         ]. It is unclear whether this prominent and severe pain component reflects the tertiary nature of the cohort.
        </p>
        <p>
         Early satiety and postprandial fullness are commonly severe symptoms in both diabetic and idiopathic gastroparesis [
         <a href="#rid62">
          62,63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H259166086">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Abdominal examination may reveal epigastric distention or tenderness, but not guarding or rigidity. There may be a succussion splash. (See
         <a class="medical medical_review" href="/z/d/html/2621.html" rel="external">
          "Gastric outlet obstruction in adults", section on 'Physical examination'
         </a>
         .)
        </p>
        <p>
         Patients may have signs of the underlying disorder resulting in gastroparesis. As an example, patients with systemic sclerosis and Raynaud phenomenon may have taut skin in the hands and chest, telangiectasia, small joint arthropathy, and crackles over the lower lung fields from interstitial lung disease. In diabetic patients, gastrointestinal complications are often associated with other signs of autonomic dysfunction [
         <a href="#rid64">
          64,65
         </a>
         ]. These may include orthostatic hypotension and absence of the pupillary reaction to light with persistence of the accommodation response (the pseudo-Argyll-Robertson pupil or tonic pupil). (See
         <a class="medical medical_review" href="/z/d/html/5237.html" rel="external">
          "Tonic pupil"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7893.html" rel="external">
          "Diagnosis of and screening for hypothyroidism in nonpregnant adults", section on 'Clinical features'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7539.html" rel="external">
          "Clinical manifestations and diagnosis of systemic sclerosis (scleroderma) in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H859754">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastroparesis should be suspected in patients with nausea, vomiting, early satiety, postprandial fullness, abdominal pain, or bloating. The goal of evaluation is to exclude a mechanical obstruction and establish the diagnosis of gastroparesis by an assessment of gastric motility. Evaluation should begin with a history and physical examination.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Exclude mechanical obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients with suspected delayed gastric emptying and, in particular, patients with colicky abdominal pain should undergo a careful upper gastrointestinal endoscopy. We also perform computed tomographic (CT) enterography or magnetic resonance (MR) enterography to exclude mechanical obstruction (eg, from a small bowel mass or superior mesenteric artery syndrome). A
         <a class="drug drug_general" data-topicid="9180" href="/z/d/drug information/9180.html" rel="external">
          barium
         </a>
         follow-through examination is performed if CT/MR enterography are unavailable. The presence of retained food after an overnight period of fasting, although supportive of a diagnosis of gastroparesis, is not diagnostic.
        </p>
        <p class="headingAnchor" id="H261154964">
         <span class="h2">
          Assess gastric motility
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with suspected gastroparesis and no evidence of a mechanical obstruction on imaging or upper endoscopy, an assessment of gastric motility is necessary to establish the diagnosis of gastroparesis.
        </p>
        <p class="headingAnchor" id="H860104">
         <span class="h3">
          Scintigraphic gastric emptying
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most cost-effective, simple, and widely available technique to confirm the presence of delayed gastric emptying of solids is scintigraphy  (
         <a class="graphic graphic_figure graphicRef69354" href="/z/d/graphic/69354.html" rel="external">
          figure 2
         </a>
         ). Documenting the presence of delayed gastric emptying and assessing the severity is best achieved by evaluating the gastric emptying of solids. Since liquids often empty from the stomach normally even when solids are abnormally retained, assessment of liquid emptying is generally unnecessary unless dumping syndrome is suspected [
         <a href="#rid66">
          66,67
         </a>
         ]. If patients are too sick to tolerate a solid meal, a liquid nutrient meal containing radioisotope may be used to permit scintigraphic measurement of gastric emptying [
         <a href="#rid68">
          68
         </a>
         ]. However, it is important to establish normal values for comparison as the physical characteristics and fat content of the meal impact the rate of emptying and hence the normal values for gastric emptying [
         <a href="#rid69">
          69
         </a>
         ]. Other centers [
         <a href="#rid70">
          70
         </a>
         ] utilize real eggs or omelettes with higher fat content (~300 kcal with 30 percent fat) to test for gastroparesis arguing that the higher fat content provides an improved test for gastric motor function; the emptying profiles of different meal substrates are reviewed elsewhere [
         <a href="#rid71">
          71
         </a>
         ]. Importantly, when an optimal gastric emptying test is conducted (solid meal, sufficient calories, assessed over at least three hours), there is a good correlation between the delayed gastric emptying and symptoms [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pretest instructions
         </strong>
         –
         <strong>
         </strong>
         Medications that affect gastric emptying should be stopped at least 48 hours before diagnostic testing [
         <a href="#rid4">
          4
         </a>
         ]. Based on the pharmacokinetics of the medication, the medication may need to be stopped more than 48 hours before testing. Patients with diabetes should have blood glucose measured before starting the gastric emptying test, and hyperglycemia should be treated. The test should be performed only once blood glucose levels are &lt;180 mg/dL.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Test protocol
         </strong>
         –
         <strong>
         </strong>
         The suggested protocol involves a low fat egg-white meal with imaging immediately after meal ingestion and again at one, two, and four hours following ingestion. The meal composition may need to be altered depending upon the patient's specific symptoms. Updated normal values for (99m)Tc egg or egg substitute and consensus standards for performing and reporting gastric emptying scintigraphy have been published [
         <a href="#rid73">
          73-75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Studies suggest that scans obtained immediately after meal ingestion and two and four hours later are sufficient for most clinical indications [
         <a href="#rid73">
          73,76,77
         </a>
         ]. Several centers limit scans to two hours; this is suboptimal. However, it is important to note that for delayed gastric emptying, gastric residual at four hours has a higher sensitivity for delayed gastric emptying as compared with the two-hour measurement [
         <a href="#rid76">
          76-78
         </a>
         ]. Evaluation should be extended to four hours in patients with normal two-hour results. As an example, in one study in which scintigraphy was performed on 129 consecutive patients with suspected gastroparesis, the percentage of patients with delayed gastric emptying increased from 33 percent at two hours to 58 percent using the results of the two-, three-, and four-hour scans [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Interpretation of test results
         </strong>
         –
         <strong>
         </strong>
         Delayed gastric emptying is defined as gastric retention of &gt;10 percent at four hours and/
         <strong>
          or
         </strong>
         &gt;60 percent at two hours when using the standard low fat, scrambled egg protein meal described above [
         <a href="#rid73">
          73
         </a>
         ]. Although the severity of symptoms do not always correlate with the rate of gastric emptying, delayed gastric emptying has been classified based on the extent of gastric retention on scintigraphy at four hours into the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mild – 10 to 15 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Moderate – 15 to 35 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe – &gt;35 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Normal values for the percent remaining in the stomach at the key time points are 37 to 90 percent at one hour, 30 to 60 percent at two hours, and 0 to 10 percent at four hours. It should be noted that each institution's nuclear medicine department may have different normal values, which vary with the nature of the meal and isotope used.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Normal data have also been reported for a higher (30 percent) fat-containing "real egg" test meal with higher caloric content (298 kcl). With such a meal, gastroparesis is diagnosed when there is &gt;75 percent retained in the stomach at two hours and &gt;25 percent retained in the stomach at four hours [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H860110">
         <span class="h3">
          Alternatives to scintigraphy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Alternative approaches for assessment of gastric emptying include wireless motility capsule testing and
         <sup>
          13
         </sup>
         C breath testing using octanoate or spirulina incorporated into a solid meal [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <strong>
          Wireless motility capsule
         </strong>
         –
         <strong>
         </strong>
         A wireless motility capsule (WMC) can simultaneously measure phasic pressure amplitudes, temperature, and pH as it traverses different segments of the gastrointestinal tract [
         <a href="#rid79">
          79
         </a>
         ]. The characteristic change in pH between stomach and small intestine provides an indication of the gastric emptying time for a nondigestible solid &gt;1 cm long [
         <a href="#rid80">
          80
         </a>
         ]. A systematic review that included seven studies found that for the diagnosis of gastroparesis, as compared with gastric scintigraphy, WMC had a sensitivity of 59 to 86 percent and specificity of 64 to 81 percent [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When the WMC is given with a meal, it often emptied after five hours as it requires fasting migrating motor complex (MMC) to be emptied. In about 30 percent of occasions in healthy adults, it emptied with coordinated postprandial antral contractions; in the other healthy adults, the WMC emptied when there was a return of fasting MMCs [
         <a href="#rid82">
          82
         </a>
         ]. The amplitude of contractions immediately before emptying from the stomach can provide useful information to exclude a myopathic disorder (eg, scleroderma, amyloidosis) which are associated with low amplitude distal antral contractions (&lt;40 mmHg) [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <sup>
           13
          </sup>
         </strong>
         <strong>
          C breath testing
         </strong>
         – C
         <sup>
          13
         </sup>
         -labeled acetate, octanoic acid breath tests, or spirulina (a plant-based protein source) have been used to assess gastric emptying [
         <a href="#rid84">
          84-86
         </a>
         ]. After ingestion of the stable isotope labeled test meal, the expiratory 13-CO
         <sub>
          2
         </sub>
         concentration is measured (eg, by mass spectrometry or infrared spectroscopy). The test is noninvasive and, unlike scintigraphy, avoids radiation exposure. Most studies suggest that the accuracy of these breath tests in normal and pathologic conditions is less than that of scintigraphic measurements of gastric emptying [
         <a href="#rid85">
          85,87,88
         </a>
         ]. The spirulina
         <sup>
          13
         </sup>
         C breath test was approved by the US Food and Drug Administration to diagnose gastroparesis in April 2015 [
         <a href="#rid89">
          89
         </a>
         ]. Approval was based on the observation in a study of 115 patients who underwent simultaneous scintigraphy and spirulina
         <sup>
          13
         </sup>
         C breath test. At 80 percent specificity, the
         <sup>
          13
         </sup>
         C-spirulina breath test samples at 150 and 180 minutes had a combined sensitivity of 89 percent for delayed gastric emptying [
         <a href="#rid88">
          88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2643.html" rel="external">
          "Diabetic autonomic neuropathy of the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H859989">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastroparesis is suspected in patients with nausea, vomiting, early satiety, postprandial fullness, abdominal pain, or bloating. A mechanical obstruction is excluded with imaging (eg, computed tomography or magnetic resonance enterography) or upper endoscopy as discussed in the evaluation approach above (see
         <a class="local">
          'Evaluation'
         </a>
         above). The presence of delayed gastric emptying on scintigraphy establishes the diagnosis of gastroparesis.
        </p>
        <p class="headingAnchor" id="H264183422">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of gastroparesis includes other causes of chronic nausea and vomiting. This is discussed in detail, separately. (See
         <a class="medical medical_review" href="/z/d/html/2537.html" rel="external">
          "Approach to the adult with nausea and vomiting", section on 'Chronic disorders'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psychiatric disease
         </strong>
         – Vomiting, anorexia, and other clinical symptoms of gastroparesis may be the presentation of psychiatric diseases (eg, depression or anxiety neurosis), classical eating disorders (eg, anorexia nervosa, bulimia), psychogenic vomiting, or a side effect of a psychotropic medication.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The differentiation between an intrinsic gastric stasis syndrome and an eating disorder that includes vomiting can be very difficult. A thorough history may help (eg, in bulimia); however, physiologic abnormalities of the stomach such as gastric emptying delays or dysrhythmias have been documented in anorexic patients, rendering the distinction difficult. A high index of suspicion of an eating disorder is essential, particularly in young women with significant weight loss and an altered body perception or indifference towards weight loss. (See
         <a class="medical medical_review" href="/z/d/html/14705.html" rel="external">
          "Anorexia nervosa in adults and adolescents: Medical complications and their management", section on 'Gastroparesis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rumination syndrome
         </strong>
         – Rumination syndrome is a behavioral disorder that is most commonly identified among mentally disadvantaged children, although it is increasingly recognized among adolescents and adults of normal mental capacity, particularly among those who are highly stressed, high achievers, or perfectionists [
         <a href="#rid90">
          90-92
         </a>
         ]. The behavior consists of daily, effortless regurgitation of undigested food within minutes of starting or completing ingestion of a meal. Regurgitation is not preceded by nausea or retching. Unlike patients with gastroparesis, patients with rumination syndrome have normal gastric emptying. (See
         <a class="medical medical_review" href="/z/d/html/113568.html" rel="external">
          "Rumination syndrome", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Functional dyspepsia
         </strong>
         – Symptoms of gastroparesis overlap with those of functional dyspepsia. However, early satiety, postprandial fullness, and epigastric pain or burning are the predominant symptoms in patients with functional dyspepsia and, in contrast, nausea, vomiting, and weight loss are the predominant symptoms in patients with gastroparesis. In contrast to patients with gastroparesis, gastric emptying is normal in patients with functional dyspepsia, but one-third of patients with functional dyspepsia have slow emptying. The National Institutes of Health (NIH) gastroparesis consortium data also identified overlap of diagnosis during follow-up, as patients originally diagnosed as gastroparesis subsequently fulfilled criteria for functional dyspepsia and vice-versa [
         <a href="#rid63">
          63
         </a>
         ]. Therefore, a gastric emptying test with definite cut-off criteria for diagnosing gastroparesis (eg, 300 kcal, 30 percent fat egg meal and &gt;25 percent retained in the stomach at four hours, and/or &gt;75 percent retained at two hours) is recommended based on normal value data acquired in 319 healthy adults [
         <a href="#rid70">
          70
         </a>
         ]. It is unclear whether "chronic unexplained nausea and vomiting" included as a subcategory in Rome IV criteria is an entity distinct from gastroparesis or functional dyspepsia. (See
         <a class="medical medical_review" href="/z/d/html/19.html" rel="external">
          "Functional dyspepsia in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cyclic vomiting syndrome
         </strong>
         – Cyclic vomiting syndrome (CVS) refers to recurrent episodes of intense nausea and vomiting lasting hours to days separated by symptom-free periods of variable lengths. CVS is mimicked by cannabinoid hyperemesis [
         <a href="#rid93">
          93
         </a>
         ]. Gastric emptying is rapid in some patients with CVS during symptom-free periods. (See
         <a class="medical medical_review" href="/z/d/html/2588.html" rel="external">
          "Cyclic vomiting syndrome", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2588.html" rel="external">
          "Cyclic vomiting syndrome", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H259167102">
         <span class="h1">
          ESTABLISHING THE ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once the diagnosis of gastroparesis is established, the underlying etiology should be determined. In patients with gastroparesis in whom there is a known underlying disease, no further investigation is necessary. In patients with gastroparesis and no known underlying disease, we perform laboratory testing. We perform gastroduodenal manometry in patients without an identifiable etiology despite laboratory testing. Autonomic testing is useful in patients with evidence of neuropathic dysmotility on manometry, but without a known underlying neurologic disorder  (
         <a class="graphic graphic_algorithm graphicRef80893" href="/z/d/graphic/80893.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H259167108">
         <span class="h2">
          Laboratory studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory testing may help to identify diseases associated with delayed gastric emptying. We obtain the following tests: hemoglobin, fasting plasma glucose, serum total protein, albumin, thyrotropin (TSH), and an antinuclear antibody (ANA) titer. In patients with diabetes, we obtain an HbA1c to assess their glycemic control. In patients with a long-standing history of smoking, we test for ANNA-1 or anti-Hu antibody in search for paraneoplastic gastroparesis. In patients with multiple symptoms suggesting other neurological or autonomic (including bladder, sweating, postural dizziness), we perform additional laboratory tests for evidence of viral infection or autoimmune process directed to nicotinic acetyl choline receptors. (See
         <a class="local">
          'Viral'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H259167134">
         <span class="h2">
          Gastroduodenal manometry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Manometry can help differentiate a myopathic process (eg, amyloid and scleroderma) from a neuropathic process (eg, diabetes mellitus, amyloid neuropathy, and idiopathic autonomic neuropathy), if this distinction cannot be achieved by other tests (eg, gastric emptying, blood tests or tissue diagnosis). Myopathic disorders are typically associated with low amplitude contractions (mean &lt;40 mmHg in antrum), whereas in neuropathic disorders the amplitude of contractions is typically normal, but the organization of the contractile response is abnormal and there is a persistence of fasting motor patterns after meal ingestion [
         <a href="#rid94">
          94
         </a>
         ]. High resolution water-perfused antropyloroduodenal and jejunal manometry may identify antral, pyloric, or small intestinal dysmotility that may aid in selection of therapy (eg, pharmacologic stimulation or pyloromyotomy) [
         <a href="#rid95">
          95,96
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2456437971">
         <span class="h2">
          Identification of pylorospasm or reduced pyloric compliance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multilumen manometry or Endoflip can identify pylorospasm [
         <a href="#rid97">
          97
         </a>
         ] or reduced diameter or compliance or distensibility of the pylorus [
         <a href="#rid98">
          98
         </a>
         ]. Evaluation for pylorospasm or reduced compliance is increasingly relevant as gastric per-oral endoscopic myotomy or laparoscopic pyloroplasty is being offered as a treatment for gastroparesis. It is important to note that opioid stimulation results in pylorospasm as well as gastroparesis with antral hypomotility [
         <a href="#rid99">
          99
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2532.html" rel="external">
          "Treatment of gastroparesis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H259167160">
         <span class="h2">
          Autonomic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Autonomic testing may be useful in patients with a neuropathic pattern on manometry to further define the etiology of gastric stasis  (
         <a class="graphic graphic_table graphicRef82750" href="/z/d/graphic/82750.html" rel="external">
          table 1
         </a>
         ). These tests permit differentiation of a preganglionic or central lesion from a peripheral neuropathy associated with autonomic dysfunction. In patients in whom a central lesion is suspected, brain and spinal cord magnetic resonance imaging (MRI) should be performed. In patients with a peripheral dysautonomia, further screening for a toxic (eg, lead poisoning), metabolic (eg, porphyria), or paraneoplastic process (eg, lung cancer) should be performed  (
         <a class="graphic graphic_algorithm graphicRef80893" href="/z/d/graphic/80893.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H259167172">
         <span class="h2">
          Other tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several other tests have been used in patients with gastroparesis but are predominantly research tools. Their role in clinical practice has not been defined.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Electrogastrogram
         </strong>
         –
         <strong>
         </strong>
         Cutaneous electrogastrogram (EGG), involves placement of surface electrodes to record the electrical control activity or "pacemaker" of the stomach  (
         <a class="graphic graphic_figure graphicRef66624" href="/z/d/graphic/66624.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid100">
          100,101
         </a>
         ]. Alterations in frequency (bradygastria, tachygastria, or mixed) and reduction in the amplitude ("power") of the postprandial electrical signal are seen in patients with idiopathic and diabetic gastroparesis, anorexia nervosa, vector/motor sickness, and nausea of pregnancy. Dysrhythmias have also been described in patients with nonulcer dyspepsia, with or without evidence of gastric stasis. The precise role of EGG in the clinical evaluation and management of patients with gastroparesis is the subject of ongoing research [
         <a href="#rid100">
          100,101
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Single photon emission computed tomography (SPECT)
         </strong>
         –
         <strong>
         </strong>
         The accommodation response is related to early satiety and bloating postprandially. SPECT has been used to characterize postprandial accommodation in a variety of upper gut dysmotilities [
         <a href="#rid102">
          102-104
         </a>
         ]. SPECT may help to identify subgroups of patients with gastroparesis that are candidates for more selective pharmacotherapy. MRI measurements have also been used to measure gastric accommodation [
         <a href="#rid105">
          105
         </a>
         ]. In a cohort of approximately 100 patients with diabetes and upper gastrointestinal symptoms (16.7 percent with a history of opioid use), there were almost equal numbers with abnormal gastric emptying, abnormal gastric accommodation, both abnormal or neither abnormal [
         <a href="#rid106">
          106
         </a>
         ]. Increased gastric accommodation volume is associated with slower gastric emptying rate [
         <a href="#rid107">
          107
         </a>
         ], and this may explain the potential benefit of sleeve gastrectomy in patients with significant gastro-esophageal reflux reported in an uncontrolled study [
         <a href="#rid108">
          108
         </a>
         ]. It is important to note that the results of sleeve gastrectomy require confirmation with sham-controlled trials in patients with gastroparesis, including documentation of the gastric fasting and post-meal or accommodation volume.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Full thickness gastric and small intestinal biopsy
         </strong>
         –
         <strong>
         </strong>
         Pathological examination of full thickness gastric and small intestinal biopsies may provide confirmation of the organic nature of the gastric stasis and may provide prognostic information [
         <a href="#rid109">
          109
         </a>
         ]. Full thickness biopsy should not be performed outside of research studies [
         <a href="#rid3">
          3
         </a>
         ]. In the largest series of 101 patients in a referral practice with refractory and unexplained nausea and vomiting, a high incidence of small bowel morphologic abnormalities (primarily neuropathies) was reported [
         <a href="#rid110">
          110
         </a>
         ]. The histologic abnormalities in gastroparesis are heterogeneous and include myenteric inflammation, decreased innervation, reduced number of interstitial cells of Cajal (ICC), and rarely muscle fibrosis [
         <a href="#rid111">
          111,112
         </a>
         ]. Absence of ICCs was associated with abnormalities of gastric slow waves, worse symptoms of gastroparesis, and less improvement with gastric electrical stimulation [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1723099881">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117173.html" rel="external">
          "Society guideline links: Gastroparesis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H174040348">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15732.html" rel="external">
          "Patient education: Upper endoscopy (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16403.html" rel="external">
          "Patient education: Gastroparesis (delayed gastric emptying) (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/1992.html" rel="external">
          "Patient education: Upper endoscopy (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Gastroparesis is a syndrome of objectively delayed gastric emptying in the absence of a mechanical obstruction and cardinal symptoms of nausea, vomiting, early satiety, bloating, and/or upper abdominal pain. (See
         <a class="local">
          'Definition'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology
         </strong>
         – Although multiple conditions have been associated with gastroparesis, the majority of cases are idiopathic, diabetic, or postsurgical. (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Patients with gastric stasis present with nausea, vomiting, abdominal pain, early satiety, postprandial fullness, bloating, and, in severe cases, weight loss. While abdominal pain is a frequent symptom in patients with gastroparesis, it is rarely the predominant symptom. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – Gastroparesis should be suspected in patients with nausea, vomiting, early satiety, abdominal pain or bloating. We perform upper endoscopy followed if clinically indicated by computed tomography/magnetic resonance enterography to exclude mechanical obstruction or mucosal disease as a cause of impaired gastric emptying. Delayed gastric emptying on scintigraphy is required to establish the diagnosis of gastroparesis  (
         <a class="graphic graphic_algorithm graphicRef80893" href="/z/d/graphic/80893.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         On scintigraphy, delayed gastric emptying is defined as gastric retention of &gt;10 percent at four hours and/
         <strong>
          or
         </strong>
         &gt;60 percent at two hours when using the 250 kcal, 2 percent fat egg protein meal. Alternatively, the cut-offs are &gt;75 percent at two hours and &gt;25 percent at four hours when using the 300 kcal, 30 percent fat "real egg" meal. (See
         <a class="local">
          'Evaluation'
         </a>
         above and
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Routine evaluation to determine the underlying etiology
         </strong>
         – Once the diagnosis of gastroparesis is established, the underlying etiology should be determined. In patients with gastroparesis and no known underlying disease, we obtain the following laboratory tests: hemoglobin, fasting plasma glucose, serum total protein, albumin, thyrotropin (TSH) concentrations, and antinuclear antibody titer. (See
         <a class="local">
          'Laboratory studies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Additional evaluation in patients without a clear etiology
         </strong>
         – In patients with gastroparesis without an identifiable cause despite laboratory testing, we perform gastroduodenal manometry provided that the expertise is available. Manometry can help differentiate a myopathic process from a neuropathic process. We perform autonomic testing in patients with a neuropathic pattern on manometry to further define the etiology of gastric stasis  (
         <a class="graphic graphic_algorithm graphicRef80893" href="/z/d/graphic/80893.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Gastroduodenal manometry'
         </a>
         above and
         <a class="local">
          'Autonomic testing'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lacy BE, Parkman HP, Camilleri M. Chronic nausea and vomiting: evaluation and treatment. Am J Gastroenterol 2018; 113:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127:1592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M, Kuo B, Nguyen L, et al. ACG Clinical Guideline: Gastroparesis. Am J Gastroenterol 2022; 117:1197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung HK, Choung RS, Locke GR 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ye Y, Jiang B, Manne S, et al. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut 2021; 70:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dilmaghani S, Zheng T, Camilleri M. Epidemiology and Healthcare Utilization in Patients With Gastroparesis: A Systematic Review. Clin Gastroenterol Hepatol 2023; 21:2239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Syed AR, Wolfe MM, Calles-Escandon J. Epidemiology and Diagnosis of Gastroparesis in the United States: A Population-based Study. J Clin Gastroenterol 2020; 54:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43:2398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161:1989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janatuinen E, Pikkarainen P, Laakso M, Pyörälä K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 1993; 28:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol 1994; 32:637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000; 160:2808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24:1264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kong MF, Horowitz M, Jones KL, et al. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choung RS, Locke GR 3rd, Schleck CD, et al. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol 2012; 107:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parkman HP, Yates K, Hasler WL, et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol 2011; 9:1056.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ordög T, Takayama I, Cheung WK, et al. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49:1731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forster J, Damjanov I, Lin Z, et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vittal H, Farrugia G, Gomez G, Pasricha PJ. Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies. Nat Clin Pract Gastroenterol Hepatol 2007; 4:336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi KM, Gibbons SJ, Nguyen TV, et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology 2008; 135:2055.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi KM, Kashyap PC, Dutta N, et al. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology 2010; 138:2399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gangula PR, Mukhopadhyay S, Ravella K, et al. Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats. Am J Physiol Gastrointest Liver Physiol 2010; 298:G692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bharucha AE, Daley SL, Low PA, et al. Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis. Neurogastroenterol Motil 2016; 28:1731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duffey K, Hannon M, Yoo J, et al. The impact of risk factors on gastroparesis at an urban medical center. Ann Gastroenterol 2020; 33:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meeroff JC, Schreiber DS, Trier JS, Blacklow NR. Abnormal gastric motor function in viral gastroenteritis. Ann Intern Med 1980; 92:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigurdsson L, Flores A, Putnam PE, et al. Postviral gastroparesis: presentation, treatment, and outcome. J Pediatr 1997; 131:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes. Am J Gastroenterol 1997; 92:1501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naftali T, Yishai R, Zangen T, Levine A. Post-infectious gastroparesis: clinical and electerogastrographic aspects. J Gastroenterol Hepatol 2007; 22:1423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oh JJ, Kim CH. Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history. Mayo Clin Proc 1990; 65:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology 1991; 100:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lobrano A, Blanchard K, Abell TL, et al. Postinfectious gastroparesis related to autonomic failure: a case report. Neurogastroenterol Motil 2006; 18:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeong ID, Camilleri M, Shin A, et al. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Aliment Pharmacol Ther 2012; 35:1088.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouras EP, Talley NJ, Camilleri M, et al. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2008; 103:2043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 2003; 52:1555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linnebjerg H, Park S, Kothare PA, et al. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept 2008; 151:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wright AB, McKelvey GM, Wood AK, Post EJ. Effects of promethazine on porcine gastroduodenal function: a sonographic study. Ultrasound Med Biol 1999; 25:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atieh J, Sack J, Thomas R, et al. Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series. Dig Dis Sci 2021; 66:1974.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fich A, Neri M, Camilleri M, et al. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol 1990; 12:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lu D, Altieri MS, Yang J, et al. Investigating rates of reoperation or postsurgical gastroparesis following fundoplication or paraesophageal hernia repair in New York State. Surg Endosc 2019; 33:2886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Samin KA, Alam I, Riaz S, et al. Gastro-ileal stenosis and gastroparesis after a biliopancreatic diversion. Obes Surg 2006; 16:1243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salameh JR, Schmieg RE Jr, Runnels JM, Abell TL. Refractory gastroparesis after Roux-en-Y gastric bypass: surgical treatment with implantable pacemaker. J Gastrointest Surg 2007; 11:1669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davion T, Delamarre J, Reix N, et al. Gastric bezoar: another side effect of endoscopic variceal sclerotherapy. Scand J Gastroenterol 1989; 24:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masclee AA, Lamers CB. Effect of endoscopic sclerotherapy of esophageal varices on vagus nerve integrity. J Hepatol 1994; 21:724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radaelli F, Paggi S, Terreni N, et al. Acute reversible gastroparesis and megaduodenum after botulinum toxin injection for achalasia. Gastrointest Endosc 2010; 71:1326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park SY, Camilleri M, Packer D, Monahan K. Upper gastrointestinal complications following ablation therapy for atrial fibrillation. Neurogastroenterol Motil 2017; 29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jost WH. Gastrointestinal dysfunction in Parkinson's Disease. J Neurol Sci 2010; 289:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen L, Wilson LA, Miriel L, et al. Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity. Neurogastroenterol Motil 2020; 32:e13810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhamija R, Tan KM, Pittock SJ, et al. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol 2008; 6:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasha SF, Lunsford TN, Lennon VA. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 2006; 131:1592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark MB, Davis T. A pediatric case of severe pandysautonomia responsive to plasmapheresis. J Child Neurol 2013; 28:1716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soota K, Kedar A, Nikitina Y, et al. Immunomodulation for treatment of drug and device refractory gastroparesis. Results Immunol 2016; 6:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashat M, Lewis A, Liaquat H, et al. Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis-an open-label study. Neurogastroenterol Motil 2018; 30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998; 93:1085.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999; 94:1029.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasler WL, Wilson LA, Parkman HP, et al. Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol 2011; 106:1492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M. Management of patients with chronic abdominal pain in clinical practice. Neurogastroenterol Motil 2006; 18:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cherian D, Sachdeva P, Fisher RS, Parkman HP. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol 2010; 8:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parkman HP, Wilson LA, Hasler WL, et al. Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life. Dig Dis Sci 2019; 64:2242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parkman HP, Sharkey EP, Nguyen LA, et al. Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit. Dig Dis Sci 2020; 65:2311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parkman HP, Hallinan EK, Hasler WL, et al. Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing. Neurogastroenterol Motil 2017; 29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasricha PJ, Grover M, Yates KP, et al. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features. Gastroenterology 2021; 160:2006.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           KASSANDER P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 1958; 48:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim CH, Kennedy FP, Camilleri M, et al. The relationship between clinical factors and gastrointestinal dysmotility in diabetes mellitus. J Gastrointest Motil 1991; 3:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziessman HA, Chander A, Clarke JO, et al. The added diagnostic value of liquid gastric emptying compared with solid emptying alone. J Nucl Med 2009; 50:726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziessman HA, Okolo PI, Mullin GE, Chander A. Liquid gastric emptying is often abnormal when solid emptying is normal. J Clin Gastroenterol 2009; 43:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sachdeva P, Kantor S, Knight LC, et al. Use of a high caloric liquid meal as an alternative to a solid meal for gastric emptying scintigraphy. Dig Dis Sci 2013; 58:2001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M, Shin A. Novel and validated approaches for gastric emptying scintigraphy in patients with suspected gastroparesis. Dig Dis Sci 2013; 58:1813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M, Iturrino J, Bharucha AE, et al. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil 2012; 24:1076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M. Novel Diet, Drugs, and Gastric Interventions for Gastroparesis. Clin Gastroenterol Hepatol 2016; 14:1072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vijayvargiya P, Jameie-Oskooei S, Camilleri M, et al. Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis. Gut 2019; 68:804.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95:1456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cremonini F, Mullan BP, Camilleri M, et al. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002; 16:1781.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103:753.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M, Zinsmeister AR, Greydanus MP, et al. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 1991; 36:609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomforde GM, Camilleri M, Phillips SF, Forstrom LA. Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med 1995; 36:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guo JP, Maurer AH, Fisher RS, Parkman HP. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001; 46:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuo B, Viazis N, Bahadur S, et al. Non-invasive simultaneous measurement of intra-luminal pH and pressure: assessment of gastric emptying and upper GI manometry in healthy subjects. Neurogastroenterology 2004; 16:666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther 2008; 27:186.
          </a>
         </li>
         <li class="breakAll">
          Agency for Healthcare Research and Quality (AHRQ). Wireless motility capsule versus other diagnostic technologies for evaluating gastroparesis and constipation: A comparative effectiveness review (No. 110). Available at: http://effectivehealthcare.ahrq.gov/ehc/products/392/1498/Constipation-gastroparesis-wireless-capsule-report-130520.pdf (Accessed on June 07, 2013).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cassilly D, Kantor S, Knight LC, et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008; 20:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol 1997; 92:1496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghoos YF, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104:1640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braden B, Adams S, Duan LP, et al. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 1995; 108:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JS, Camilleri M, Zinsmeister AR, et al. A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut 2000; 46:768.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maes BD, Ghoos YF, Rutgeerts PJ, et al. [*C]octanoic acid breath test to measure gastric emptying rate of solids. Dig Dis Sci 1994; 39:104S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szarka LA, Camilleri M, Vella A, et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008; 6:635.
          </a>
         </li>
         <li class="breakAll">
          US Food and Drug Administration (FDA) news release. FDA approves breath test to aid in diagnosis of delayed gastric emptying. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm441370.htm (Accessed on April 07, 2015).
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology 1995; 108:1024.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chial HJ, Camilleri M, Williams DE, et al. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics 2003; 111:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Attri N, Ravipati M, Agrawal P, et al. Rumination syndrome: an emerging case scenario. South Med J 2008; 101:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004; 53:1566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M, Hasler WL, Parkman HP, et al. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zheng T, BouSaba J, Sannaa W, et al. Comprehensive characterization of antral and pyloric contractions by high resolution manometry: applied physiology in suspected gastroparesis. Am J Physiol Gastrointest Liver Physiol 2022; 323:G255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alcala-Gonzalez LG, Malagelada C, Galan C, et al. Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry. Neurogastroenterol Motil 2021; 33:e14240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90:1919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watts LS, Baker JR, Lee AA, et al. Impact of gastric per-oral endoscopic myotomy on static and dynamic pyloric function in gastroparesis patients. Neurogastroenterol Motil 2020; 32:e13892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camilleri M, Sanders KM. Opiates, the Pylorus, and Gastroparesis. Gastroenterology 2020; 159:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sha W, Pasricha PJ, Chen JD. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J Clin Gastroenterol 2009; 43:716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friesen CA, Lin Z, Hyman PE, et al. Electrogastrography in pediatric functional dyspepsia: relationship to gastric emptying and symptom severity. J Pediatr Gastroenterol Nutr 2006; 42:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuiken SD, Samsom M, Camilleri M, et al. Development of a test to measure gastric accommodation in humans. Am J Physiol 1999; 277:G1217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouras EP, Delgado-Aros S, Camilleri M, et al. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut 2002; 51:781.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bredenoord AJ, Chial HJ, Camilleri M, et al. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 2003; 1:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fidler J, Bharucha AE, Camilleri M, et al. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil 2009; 21:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chedid V, Brandler J, Vijayvargiya P, et al. Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center. Am J Gastroenterol 2019; 114:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang XJ, Burton DD, Breen-Lyles M, Camilleri M. Gastric accommodation influences proximal gastric and total gastric emptying in concurrent measurements conducted in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2021; 320:G759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salman MA, Mikhail HMS, Abdelsalam A, et al. Acceleration of Gastric Emptying and Improvement of GERD Outcome After Laparoscopic Sleeve Gastrectomy in Non-diabetic Obese Patients. Obes Surg 2020; 30:2676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grover M, Bernard CE, Pasricha PJ, et al. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil 2012; 24:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abell TL, Familoni B, Voeller G, et al. Electrophysiologic, morphologic, and serologic features of chronic unexplained nausea and vomiting: lessons learned from 121 consecutive patients. Surgery 2009; 145:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci 2010; 55:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasricha PJ, Pehlivanov ND, Gomez G, et al. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol 2008; 8:21.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2640 Version 31.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29545633" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Chronic nausea and vomiting: evaluation and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15521026" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35926490" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : ACG Clinical Guideline: Gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23147521" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Clinical guideline: management of gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19249393" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32493829" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35870768" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Epidemiology and Healthcare Utilization in Patients With Gastroparesis: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31135630" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Epidemiology and Diagnosis of Gastroparesis in the United States: A Population-based Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9824125" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11525701" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8511503" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Gastrointestinal symptoms in middle-aged diabetic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7886972" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11025791" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Gastrointestinal tract symptoms among persons with diabetes mellitus in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11423513" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Predictors of delayed gastric emptying in diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10097936" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Natural history of diabetic gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2070801" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22085818" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21871247" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Similarities and differences between diabetic and idiopathic gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11016458" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15623450" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17541447" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18926825" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20178793" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20185690" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27283929" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32382227" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The impact of risk factors on gastroparesis at an urban medical center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6766695" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Abnormal gastric motor function in viral gastroenteritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9403659" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Postviral gastroparesis: presentation, treatment, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9317072" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17716347" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Post-infectious gastroparesis: clinical and electerogastrographic aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2348727" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1983829" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16420295" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Postinfectious gastroparesis related to autonomic failure: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22348605" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18803000" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14570722" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18675854" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10320313" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Effects of promethazine on porcine gastroduodenal function: a sonographic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32594464" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2229993" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30478699" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Investigating rates of reoperation or postsurgical gastroparesis following fundoplication or paraesophageal hernia repair in New York State.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16989712" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Gastro-ileal stenosis and gastroparesis after a biliopancreatic diversion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17906904" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Refractory gastroparesis after Roux-en-Y gastric bypass: surgical treatment with implantable pacemaker.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2799285" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Gastric bezoar: another side effect of endoscopic variceal sclerotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7890885" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Effect of endoscopic sclerotherapy of esophageal varices on vagus nerve integrity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20304403" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Acute reversible gastroparesis and megaduodenum after botulinum toxin injection for achalasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28524623" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Upper gastrointestinal complications following ablation therapy for atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19717168" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Gastrointestinal dysfunction in Parkinson's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32061038" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18599359" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17101331" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23358630" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : A pediatric case of severe pandysautonomia responsive to plasmapheresis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27014566" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Immunomodulation for treatment of drug and device refractory gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29205691" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis-an open-label study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9672335" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10201478" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pain: the overlooked symptom in gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21483459" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Bloating in gastroparesis: severity, impact, and associated factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16771765" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Management of patients with chronic abdominal pain in clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20472097" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Abdominal pain is a frequent symptom of gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30852767" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31758430" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27781342" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33548234" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13521605" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The relationship between clinical factors and gastrointestinal dysmotility in diabetes mellitus
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19372480" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The added diagnostic value of liquid gastric emptying compared with solid emptying alone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19623689" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Liquid gastric emptying is often abnormal when solid emptying is normal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23589143" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Use of a high caloric liquid meal as an alternative to a solid meal for gastric emptying scintigraphy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23695877" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Novel and validated approaches for gastric emptying scintigraphy in patients with suspected gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22747676" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26762845" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Novel Diet, Drugs, and Gastric Interventions for Gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29860241" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10894578" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Assessment of gastric emptying using a low fat meal: establishment of international control values.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12269971" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Performance characteristics of scintigraphic transit measurements for studies of experimental therapies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18028513" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2022162" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Towards a less costly but accurate test of gastric emptying and small bowel transit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7799090" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Evaluation of an inexpensive screening scintigraphic test of gastric emptying.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11270790" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Non-invasive simultaneous measurement of intra-luminal pH and pressure: assessment of gastric emptying and upper GI manometry in healthy subjects
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17973643" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17973643" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18194154" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9317071" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8500721" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7698571" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10807886" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : A valid, accurate, office based non-radioactive test for gastric emptying of solids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7995200" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : [*C]octanoic acid breath test to measure gastric emptying rate of solids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18406670" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18406670" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7698568" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : The rumination syndrome: clinical features rather than manometric diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12509570" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18360346" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Rumination syndrome: an emerging case scenario.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15479672" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9721173" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Measurement of gastrointestinal motility in the GI laboratory.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35819155" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Comprehensive characterization of antral and pyloric contractions by high resolution manometry: applied physiology in suspected gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34378830" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3699409" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Pyloric dysfunction in diabetics with recurrent nausea and vomiting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32542920" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Impact of gastric per-oral endoscopic myotomy on static and dynamic pyloric function in gastroparesis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32389662" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Opiates, the Pylorus, and Gastroparesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19247205" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16540794" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Electrogastrography in pediatric functional dyspepsia: relationship to gastric emptying and symptom severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10600819" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Development of a test to measure gastric accommodation in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12427776" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15017667" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19019018" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30166634" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33719546" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Gastric accommodation influences proximal gastric and total gastric emptying in concurrent measurements conducted in healthy volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32200446" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Acceleration of Gastric Emptying and Improvement of GERD Outcome After Laparoscopic Sleeve Gastrectomy in Non-diabetic Obese Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22339929" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19375605" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Electrophysiologic, morphologic, and serologic features of chronic unexplained nausea and vomiting: lessons learned from 121 consecutive patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19997975" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18513423" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
